Immunotherapy increases chances of cure in breast cancer
A new study has shown that adding a type of therapy that activates the immune system, called pembrolizumab, to traditional chemotherapy improves the prognosis and even the chances of recovery for patients with the most aggressive type of breast cancer, triple negative, in a localized state, according to the promoters of this trial. The new … Read more